The Mount Sinai Hospital has performed New York City's first procedure using the HYDROS™ Robotic System, a cutting-edge ...
The Mount Sinai Hospital has performed New York City's first procedure using the HYDROS Robotic System, a cutting-edge technology designed to treat benign prostatic hyperplasia (BPH), or an enlarged ...
Discover how recent advancements in ejaculation-preserving techniques during HoLEP have yielded encouraging results.
Announcing a new publication for Acta Materia Medica journal. Prostate cancer (PrCa) is the most prevalent urogenital cancer affecting men.
Traditional approaches to prostate cancer screening involve blood tests, MRI, and biopsies. However, in addition to being ...
The FDA granted fast track designation to 64Cu-SAR-bisPSMA for PET imaging of PSMA-positive prostate cancer lesions in ...
Do you consider the cancer measurements to be small, thus making the “observation only” protocol correct? — B.A. Dear B.A.: ...
Prostate cancer is the second most common cancer affecting men globally, with diagnostic methods and risk assessment ...